PQ401
SIGMA/P0113 - ≥98% (HPLC), powder
Synonym: IGF-1R Inhibitor II; N-
CAS Number: 196868-63-0
Empirical Formula (Hill Notation): C18H16ClN3O2
Molecular Weight: 341.79
MDL Number: MFCD00160558
Linear Formula: C18H16ClN3O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C18H16ClN3O2/c1-11-9-1 |
| InChI key | YBLWOZUPHDKFOT-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(Cl)cc1NC(=O)Nc2cc |
| solubility | DMSO: >10 mg/mL |
| H2O: <2 mg/mL | |
| storage temp. | 2-8°C |
| Application: | PQ401 has been used as: • an insulin growth factor-1 receptor (IGF-IR) inhibitor in H1299 cells to test its effect on migration suppression • a reference inhibitor in dose-response measurements studies • an IGF1R inhibitor in sirtuin 6 (SIRT6)-deficient cardiomyocytes to test its effect on hypertrophy inhibition |
| Biochem/physiol Actions: | PQ401 is an insulin growth factor-1 receptor (IGF-1R) inhibitor. |
| Biochem/physiol Actions: | PQ401, a diaryl urea compound that serves as an anti-glioma agent. |
| Features and Benefits: | This compound is a featured product for Kinase Phosphatase Biology research. Click here to discover more featured Kinase Phosphatase Biology products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the InsR page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10 mg in glass bottle |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

